Is colorectal surveillance indicated in patients with PTEN mutations?
Marry H. Nieuwenhuis(Netherlands Consortium for Healthy Ageing), Hans F. A. Vasen(Leiden University Medical Center), Stefan Aretz(University of Bonn), Karl Heinimann(University Hospital of Basel), Noralane M. Lindor(Mayo Clinic in Arizona), C. Marleen Kets, Chrystelle Colas(Institut Curie), Maureen Murphy‐Ryan(Mayo Clinic in Arizona), Allan D. Spigelman(Cancer Institute of New South Wales), Susanne Timshel, Pål Møller(Unknown), Fiona Douglas(University of Southern California), Maran J.W. Olderode-Berends(University Medical Center Groningen), E. Gómez(Maastricht University Medical Centre), S V Hodgson, Frederik J. Hes(Leiden University Medical Center)
Cited by 34
Related Papers
Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma
|The American Journal of Human Genetics|2001|1.1k
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
|JNCI Journal of the National Cancer Institute|2013|946
Germline <i>BRCA</i> Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
|Journal of Clinical Oncology|2013|833
Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer
|Gastroenterology|1997|753
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
|Nature Communications|2020|694